Drugmaker reports 4 additional deaths linked to Byetta
Drugmaker Amylin Pharmaceuticals says there have been four deaths
from their diabetes med Byetta in addition to the two reported by
the U.S. Food and Drug Administration (FDA) last week. These four
deaths did involve cases of pancreatitis, but not the necrotizing
form of the disease, the drugmaker reported, which is why they were
missed in the FDA report.
Read full story >
See all Diabetes News













